EGFR alterations with subsequent protein overexpression activate a plethora of signaling pathways, including PI3K/Akt and extracellular signal-regulated kinase (ERK1/2), which promote tumor proliferation, resistance to apoptosis, chemoradioresistance, and GBM tumor recurrence [10]. This evidence concerns the gene AKT1 and neoplasm.